-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$33.50-25.49% Downside
Cerevel Therapeutics Holdings, Inc. Frequently Asked Questions
-
What analysts cover Cerevel Therapeutics Holdings, Inc.?
Cerevel Therapeutics Holdings, Inc. has been rated by research analysts at J.P. Morgan, Mizuho Securities in the past 90 days.